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     The aim of this study was to propose a method for improving the power of recognition and 
classification of thromboembolic syndrome based on the analysis of ‎ gene expression data using 
artificial neural networks. The studied method was performed on a dataset which contained data about 
117 patients admitted to a hospital in Durham in 2009. Of all the studied patients, 66 patients were 
suffering from thromboembolic syndrome and 51 people were enrolled in the study as the control 
group. The gene expression level of 22277 was measured for all the samples and was entered into the 
model as the main variable. Due to the high number of variables, principal components analysis and 
auto-encoder neural network methods were used in order to reduce the dimension of data. The results 
showed that when using auto-encoder networks, the classification accuracy was 93.12. When using the PCA 
method to reduce the size of the data, the obtained accuracy was 78.26, and hence a significant difference in 
the accuracy of classification was observed. If auto-encoder network method is used, the sensitivity and 
specificity will be 92.58 and 93.68 and when PCA method is used, they will be 0.77 and 0.78 respectively. 
The results suggested that auto-encoder networks, compared with the PCA method, had a higher level of 
accuracy for the classification of thromboembolic syndrome status. 
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INTRODUCTION  
     Venous thromboembolism (VTE)‎syndrome 
is a disease which includes deep vein 
thrombosis (DVT) and pulmonary embolism 
(PE). Embolism is the penetration of 
something into the bloodstream and its 
subsequent movement in the direction of blood 
circulation; in addition, thromboembolism is 
an embolism caused by a blood clot. When a 
blood clot is formed within a blood vessel, its 
movement in the blood and its transfer to 
another place is called thromboembolism[1]. 
Moreover, deep vein thrombosis occurs when 
the blood in deep veins moves more slowly 
than usual or when there are factors that 
increase the tendency of blood to form a clot; 
furthermore, when the internal layer of the 
vein is damaged, the probability of deep vein 
thrombosis also increases. The formation of 
clots in the inner  
lining of deep veins is dangerous, because 
these clots may break off and enter the 
bloodstream and they may block the important 
arteries, more specificallythe major arteries of 
the lungs and lead to permanent damage or 
death [2]. 
This disorder, which is one of the most 
important threats to life, occurs in half of the 
patients either admitted or not admitted to 
hospitals. More than 30% of cases of 
thromboembolic syndromes can relapse, and 
neglecting this important fact can cause long-
term complications such as high blood 
pressure, chronic thromboembolic pulmonary 
hypertension (CTPH) tso‎  dna-thrombotic 
syndrome (PTS)‎. Approximately, 70,000 cases 
of venous thromboembolism are hospitalized 
in the UK, of whom 12% die during 
hospitalization period and about 30% die after 
three years [3]. 
All the predisposing factors of thrombosis 
have not been known yet and the available 
tools are not able to identify more than half of 
the predisposing factors of thromboembolism. 
On the other hand, the presence of pre-
coagulation or thrombophilia factors is not 
 




necessarily a sign for the occurrence of 
thrombosis. In most clinical thrombosis 
syndromes, the presence of one or more 
inherited condition (lack of protein c) together 
with one or more acquired factors (pregnancy, 
immobilization, surgery) can move the 
hemostasis‎ system toward thrombosis. After 
the elimination or treatment of the acquired 
factor, due to the presence of inherited 
thrombophilia factor, the homeostasis system 
will again go to a subclinical state. The 
asymptomatic state may remain the same for 
the rest of life, or may clinically manifest itself 
again after the development of a new 
underlying acquired disease. Unfortunately, 
due to inflammatory, destructive and 
reconstructive changes in the damaged 
vascular endothelium, every case of 
thrombosis is considered as an acquired factor 
involved in the recurrence of thrombosis [4]. 
On the one hand, since many years ago the 
researches in the medical field have shown 
that some mutations can cause cancers and 
various diseases. As a consequence, studies on 
gene expression are of great importance. DNA 
microarray technology provides the possibility 
of studies on genes. In recent years, this 
technology has had a key role in biomedical 
research and has led to major developments in 
biological and biomedical fields. Hence, it is a 
field of interest to many researchers. DNA 
microarray is a collection of microscopic DNA 
spots that are connected to a solid surface such 
as glass, plastic, or silicon chip and form an 
array. Researchers have successfully used 
microarray techniques to measure the 
expression levels of large numbers of genes 
simultaneously in a variety of genomics 
analyses including drug discovery, genes 
identification, and clinical diagnosis [5]. 
Three general categories of studies which are 
conducted based on microarray technology 
are: class comparison, class discovery, and 
class prediction studies. Class comparison 
studies are intended to compare the gene 
expression profiles of two or more groups of 
patients. This type of study is aimed to identify 
the genes that have different expression levels 
in the two groups [6]. In class discovery 
studies, the aim is to discover subgroups that 
have a similar gene expression profiles in a 
dataset [7]. In class prediction studies, the aim 
is to investigate pre-defined categories, for 
example, certain types of patients with cancer 
and healthy individuals. The aim of this study 
is to use the gene expression profiles and 
distinguish the category of each case [8]. To 
perform such analyses we use statistical 
methods such as discriminate analysis and 
machine learning [9]. 
In this study, we used artificial neural 
networks as a data mining algorithm and 
conducted a class prediction study. In other 
words, we used artificial neural network 
models and examined whether it is possible to 
identify patients with syndrome and 
distinguish them from healthy people using 
gene expression data of the samples. 
One of the most important challenges of the 
microarray data analysis is the imbalance 
between the number of variables (the level of 
gene expression) and the number of samples 
available. In the study of diseases, for instance 
the case of special diseases, because of 
problems with sample collection and testing 
cost, the number of samples available is very 
limited which leads to an imbalance between 
the number of variables and the number of 
cases[10]. As a result, when using the standard 
methods of machine learning, we may face the 
problem of the low number of samples. In 
other words, the gene expression matrix will 
have a very high volume of genes and a very 
limited number of samples, and this results in 
imbalance between the number of rows and 
columns of the matrix; thus, in turn, it will 
lead to very high computational complexity 
and reduced functionality of classification 
tools. This problem which is caused due to the 
high volume of features and low number of 
samples is known as the small sample size or 
SSS [11]. 
To overcome this problem, various methods of 
dimension reduction can be used, among 
which feature selection methods and feature 
extraction techniques are the note-worthy 
ones. Feature selection methods only select a 
few features as the superior features and 
ignore the other ones. Feature extraction 
methods use linear or non-linear combination 
of all the features available and produce 
smaller sets of features [12]. 
As one of the disadvantages of feature 
selection methods, they ignore a number of 
features that may contain valuable information 
about their classification. In addition, usually 
the selection of a number of features is 
optional and from a theoretical point of view, 
 




it is not easy to select a specific number of 
features to reach an optimal performance. The 
desired number of features is typically 
determined through empirical methods [11]. 
For the classification purposes, feature 
extraction methods have a better performance 
than feature selection methods, because 
obtained features are in fact a linear or non-
linear combination of basic features and can 
cover a large part of the variance in the 
original data. 
Principle component analysis (PCA) is one of 
the most common methods of feature 
extraction. The use of PCA method helps to 
reduce the dimensions of variables without 
losing the data variables have in their 
covariance matrix [13]. Gene expression data 
are a type of data that contain a lot of variables 
which are strongly correlated with one 
another. Therefore, the use of this method 
helps to reduce the number of variables 
(genes); yet, this method only includes linear 
transformations of data while for the majority 
of the datasets, especially for gene expression 
data, we need a method that discovers non-
linear relationships too. 
Auto-encoder neural networks, first proposed 
by Hinton in 1980, are a type of artificial 
neural networks that can take inputs to the 
network and produce an output with the least 
amount of deviation. In fact, by entering the 
inputs to the network, they can compress or 
encode the data as much as possible without 
loss of data and hence they can generate a 
shorter presentation of data.  Then they try to 
reconstruct or recode the compressed data. The 
goal of training the network is to reduce the 
rate of error in data recovery, so as to achieve 
the most efficient compressed set of primary 
data [14]. Thus, in this study, we tried to 
examine the status of susceptibility to the 
disease through the selection of variables or 
the appropriate genes by reducing the size of 
data and using one of the classifiers. 
 
MATERIALS AND METHODS  
     In this applied study, the data from Luis et 
al.’s (2011) study was used. The data are 
related to the gene expression of 66 patients 
with thromboembolism and 51 healthy 
individuals as the control group who had 
referred to a hospital in the city of Durham in 
2009. All the information and datasets are 
available to the public at 
http://www.ncbi.nlm.nih.gov/geo.  The data 
have been normalized after being downloaded 
from the GEO website and sent to babelomics 
website, using the RMA algorithm [15]. The 
normalized data were inserted into a 117 × 
22277 gene expression matrix, and the 
analyses and the fitness of the model were 
completed using MATLAB software.   
The approach explored in this study consists of 
two phases. The first phase, also called 
―feature learning,‖ includes the dimension 
reduction of the variables, and second phase is 
known as ―classification‖ or ―classifier 
learning‖ phase.  
The first phase, also called dimension 
reduction phase, involves two stages. The 
first stage uses PCA and adds a number of 
random variables. The second stage 
includes entering data obtained from the 
PCA into an auto-encoder neural network. 
Thus, to reduce the dimensions of the 
variables, Karhunen–Loève Transform (K-
L) was first used, reducing the number of 
variables from 22277 to 116. This 
transform is, in fact, a technique based on 
PCA which, by applying some 
transformations in the feature values of 
PCA, can resolve the problem where the 
number of variables is a hundred times that 
of samples [16].  
The higher number of variables with respect 
to that of samples may cause problems in 
the computations related to the feature 
vector. Therefore, after applying this 
transform, the dimensions of gene 
expression matrix would be reduced to 117 
× 116. Then, 200 variables from among the 
initial variables would be selected randomly 
and added to the 116 components obtained 
from K-L transform. The purpose of adding 
these variables is to increase the chance of 
detecting and discovering the existing non-
linear relationships that are latent in the 
variables obtained from PCA.  
The outcome would, thus, be a 117 × 316 
matrix ready for entering into an auto-
encoder network. At the second stage, the 
resulting 316 variables would be entered 
into an auto-encoder network in order to 
further reduce the dimensions. The auto-
encoder network would compress the 
variables. These variables adequately 
represent the initial 22277 gene expression 
 




variables and could be used for classification 
in the second phase of the study. 
In the second phase, the classification was 
done using a Radial Basis Function (RBF) 
network, and the accuracy, sensitivity, and 
specificity were also calculated. In this phase, 
two different methods were employed for 
selecting the cluster centers: Greedy Search 
and K-means. Furthermore, the accuracy of the 
classification was also measured in order to 
examine and compare the performance of 
auto-encoder networks with the cases in which 
only K-L transform has been applied for 
reducing the dimensions. 
This study includes only one independent 
variable, that is, the amount of gene 
expression; this is a continuous, quantitative 
value and is calculated using microarray 
technology. The response variable is a binary, 
qualitative variable in which 1 represents the 
presence of the syndrome, and 0 indicates its 
absence in the sample members. 
The structure of the auto-encoder network 
applied in the study is shown in figure 1. 
 
 
Figure 1.Structure of the auto-encoder network 
 
Like all types of neural networks, auto-
encoder networks also aim at minimizing cost 
function value. Cost function, as a 
fundamental concept in network training, 
determines the difference between the 
available and the optimal solutions. In auto-
encoder networks, the desired value is 
achieved when the input values of the network 
are exactly produced in the output layer. In 
other words, an auto-encoder attempts to train 
the function , ( )W b xh , which is the output value of 
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     As mentioned earlier, the duty of auto-encoder 
network is to reduce the dimensions of input 
variables so that the new compressed set could 
adequately represent the initial variables. 
However, determining the number of these 
variables is arbitrary and is achieved by trial and 
error. In addition, when doing classifications 
using the RBF neural networks, the selection of 
the centers of clusters is done with respect to the 
number of variables entered into the network. 
Therefore, the accuracy of measurement was 
calculated after selecting various numbers of input 
variables for the RBF network and setting1/5, 
1/10, and 1/20 ratios for the number of cluster 
centers. In Table 1, the number of nodes indicates 
the number of variables entered into the RBF 
network. For instance, 20 means after the auto-
encoder network is used, 20 variables would be 
selected as the compressed representatives of the 
variables; these 20 variables would, then, be 
entered into the RBF network for the purpose of 
classification. ACC1, ACC2, and ACC3 in the 
table show, respectively, the accuracy levels of the 
network classification when the numbers of the 
centers of the clusters were 1/5, 1/10, and 1/20 
times the number of the input variables and when 
the Greedy Search was used for selecting the 
centers of the clusters. 
 
Table 1. Accuracy of classification in the Greedy Search method 
number of nodes acc1 acc2 acc3 
20 55.76 52.24 74.49 
30 49.49 60.65 90.54 
40 54.75 79.34 87.17 
50 73.48 85.54 90.57 
60 69.31 87.10 92.35 
70 79.71 84.67 93.15 
80 81.99 91.41 93.94 
90 89.71 90.68 93.12 
100 87.10 92.24 92.35 
110 89.78 89.67 94.02 
 
As Figure 2 shows, in cases where the numbers of 
the centers of the clusters are selected as 1/5, 1/10, 
and 1/20 times the number of the input variables, 
as the number of input variables increases, the 
accuracy of classification also improves. 
 
 





Figure 2. Plot of changes in the accuracy levels of 
classification in the Greedy Search method 
 
We now calculate the accuracy values using 
the K-means method. Table 2 reveals the 
calculated accuracy values obtained using the 
K-means method. In this method, as also 
evident in Figure 3, as the number of input 
variables increases, the accuracy of 
classification also increases. However, in both 
methods (viz., Greedy Search and K-means), 
after 80 features are applied, the accuracy 
values become stable as no significant changes 
in the values is observed. Thus, selecting 80, 
90, and 100 features produces almost identical 
accuracy values. 
 
Table 2. Accuracy of classification in the K-means method 
number of nodes acc1 acc2 acc3 
20 55.76 53.94 87.21 
30 54.71 64.92 91.41 
40 53.91 85.39 87.21 
50 68.26 87.28 93.15 
60 76.78 86.26 87.31 
70 85.54 87.97 92.31 
80 89.23 88.87 92.28 
90 92.28 91.44 93.49 
100 91.25 91.41 94.89 




Figure 3. Plot of changes in the accuracy levels of 
classification in the K-means method 
 
According to the results obtained, all three 
criteria of 80, 90, and 100 variables could be 
regarded as appropriate selections adequately 
representing the initial variables. However, the 
calculation of the cost function (which is, as 
stated earlier, a function of the difference 
between the network input and output 
variables) indicated that the most optimal 
results would be achieved when selecting 90 
variables.Therefore, it was revealed that using 
dimension reduction methods, the dimensions 
of the 22277 genes existing in the study could 
be reduced to only 90 variables that adequately 
represent the initial variables. The sensitivity 
and specificity values of the model are 92.58 
and 93.68, respectively. Moreover, to 
investigate whether using auto-encoder 
networks would improve the outcome of the 
classification; the accuracy level is dealt with 
under the condition that only the K-L method 
of PCA is used in the dimension reduction 
phase. That is, after the data are compressed at 
this stage, auto-encoder networks are no 
longer used for further compression. In such a 
case, the sensitivity and specificity values are 
0.77 and 0.78, respectively. 
The accuracy of prediction, using auto-encoder 
network is 93.12, and accuracy of prediction, 
without using auto-encoder network is 78.26; 
the comparison of the measurement accuracy 
values in the two models applied indicates that 
using auto-encoder networks would result in a 
significant difference in the accuracy level. 
To investigate the generalizability of the 
model with the other datasets, the other 12 
gene expression datasets were used (Table 3), 
and the prediction accuracy level was 
calculated. From among the 12 datasets that 
were used in this study, the proposed model 
showed a better performance in ten cases when 
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The calculated accuracy values related to these 
datasets are presented in Table 4. 
 
Table 4. Accuracy values of the model using an auto-
encoder network and the basic method (PCA) 
No. 
Ratio of the 
Number of 
Samples to that of 







1 0.525 93.12 78.26 
2 0.335 74.37 72.86 
3 0.0805 91.67 80.48 
4 0.066 56.09 40.27 
5 0.476 75.68 70.22 
6 0.213 81.67 75.62 
7 0.158 35.28 52.25 
8 1.009 77.14 89.15 
9 3.1 87.05 91.28 
10 0.420 66.67 64.95 
11 0.269 77.48 64.75 
12 0.421 89.76 82.16 
DISCUSSION  
     On the whole, from among the 12 datasets 
that were used in this study, the proposed 
model performed better in 9 cases when 
compared with the basic method (PCA). As 
mentioned earlier, in three of all datasets, the 
basic method showed a better performance in 
comparison with the model proposed in the 
study. Further examinations of the data 
revealed that, in two cases of these datasets 
Alon et al.’s study of colorectal cancer[18] and 
Petricoin et al.’s study of ovarian cancer[19], 
when compared with other datasets, the 
number of samples and the number of features 
are relatively closer to one another. For this 
reason, the ratio of the number of samples to 
the number of features× 100 was calculated for 
each of the 12 datasets. The ratios for the 
ovarian cancer and colorectal cancer datasets 
are 1.010 and 3.100, respectively; these are 
higher ratios compared with those for other 
datasets. Thus, the better performance of the 
basic model, in comparison with the proposed 
model (i.e., the auto-encoder network), could 
be attributed to the higher ratio of the number 
of samples to that of features compared with 
other studies. 
Furthermore, the examinations show that when 
considering the datasets with lower ratios. for 
example theFujiwara et al.’s study of 
adenocarcinoma[20] with the sample to feature 
ratio of 0.081 or Singh et al.’s study of the 
prostate cancer[21] with the ratio of 0.26, 
auto-encoder networks produce significantly 
improved results when compared with PCA 
alone. 
For the seminoma dataset in the Gashaw et.al’s 
study[22], although the calculated accuracy 
value for the basic model was higher than that 
of the model proposed in the study, it is not 
related to the higher ratio of the number of 
samples to the number of features (as it was 
the case of the ovarian cancer and colorectal 
cancer datasets). Rather, as stated before, none 
of the models performed well. In Fakoor et 
al.’s study[14] on this dataset using auto-
encoders networks along with classification by 
support vector machines, the model also 
performed poorly in the final classification so 
that using various types of auto-encoder 
networks did not result in an accuracy level of 
more than 56% in that study. 
In the end, considering the fact that not all the 
causal factors of thrombosis are known yet and 
 




that the available tools are simply unable to 
identify half of the causal factors of 
thromboembolism, it could be stated that using 
peoples’ gene expressions while applying the 
proposed model could help diagnose people 
suffering from the syndrome with a higher 
level of accuracy.  
The potential problems with most feature 
selection methods are scalability and 
generality of features. For example, Aliferis et 
al. used recursive feature elimination and 
univariate association filtering approaches to 
select a small subset of the gene expressions as 
a reduced feature set[23] or Ramaswamy et al. 
applied recursive feature elimination using 
SVM to find similarly a small number of gene 
expressions to be used as the feature space for 
the classification[24]. In these methods there is 
no possibility of applying data from various 
types of cancer to automatically form features 
which help to enhance the detection and 
diagnosis of a specific one: for example 
prostate cancer data cannot be used in 
selecting features for breast cancer detection, 
reducing the basis for feature learning.  In 
contrast to these methods, our proposed 
method can use data from different cancer 
types in the feature learning step, promising 
the potential for effective feature learning in 
the presence of very limited data sets.  
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